Company
Headquarters: Moscow, Russia
₽92.77 Billion
RUB as of Jan. 1, 2025
US$839.6 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Public Joint-Stock Company Pharmacy Chain 36.6 operates pharmacies in Russia. Its pharmacies offer health and beauty products. The company serves customers under the 36.6, Romir, and Gorzdrav brands. Public Joint-Stock Company Pharmacy Chain 36.6 was founded in 1991 and is based in Moscow, Russia.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
| Last Financial Reports Date | March 31, 2014 |
| Revenue TTM | ₽60.35 B |
| EBITDA | ₽10.24 B |
| Gross Profit TTM | ₽20.06 B |
| Profit Margin | -0.28% |
| Operating Margin | 8.14% |
| Quarterly Revenue Growth | 4.50% |
Public Joint-Stock Company Pharmacy Chain 36.6 has the following listings and related stock indices.
Stock: MOEX: APTK wb_incandescent